Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Phase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy

NCT06920251

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Recruiting

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

NCT04844528

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States

View Trial Details

Recruiting

Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma

NCT06485076

Conditions: Aggressive Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +22 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Recruiting

Preventive Application of Single-use Negative Pressure Wound Therapy (sNPWT) in the Postoperative Course of Radiotreatated Limb Sarcoma Surgery

NCT06941194

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Istituto Oncologico Veneto Padova, Italy/Padova, Italy

View Trial Details

Recruiting

Pomalidomide Plus Orelabrutinib and Zuberitamab in Untreated Mantle Cell Lymphoma

NCT07257510

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Peking University Third Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma

NCT06588868

Conditions: Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome, +13 more
Locations: AOU Ospedali Riuniti delle Marche - Clinica di Ematologia Ancona, Italy

IRCCS Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy

U.O.C. Dermatologia e Venereologia Universitaria - A.O.U. Policlinico Consorziale Bari, Italy

Policlinico S.Orsola-Malpighi - Istituto di Ematologia Bologna, Italy

View all 18 locations

View Trial Details

Recruiting

Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma

NCT07162012

Conditions: DLBCL, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Shanghai General Hospital Shanghai, China

View Trial Details

Recruiting

CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LL

NCT06064903

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: Ospedale Pediatrico Bambino Gesù Rome, Italy

View Trial Details

Recruiting

Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL

NCT06080191

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: Ospedale Pediatrico Bambino Gesù Rome, Italy

View Trial Details

Recruiting

Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia

NCT07258043

Conditions: Acute Lymphobkastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Hospital General de México Dr. Eduardo Liceaga Mexico City, Mexico

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions